SCHEDULE: OmniAb Stakeholder Reports 7.1% Ownership
Beneficial Ownership Filing
Whitefort Capital Management, LP, along with its Co-Managing Partners David Salanic and Joseph Kaplan, now beneficially own 7.1% of OmniAb, Inc. common stock.
Summary
- Whitefort Capital Management, LP, and its Co-Managing Partners David Salanic and Joseph Kaplan, have reported beneficial ownership of 10,248,658 shares of OmniAb, Inc. common stock.
- This represents 7.1% of the outstanding shares as of June 30, 2026.
- The filing is an amendment (Amendment No. 3) to a Schedule 13G.
- Whitefort Management acts as the investment manager for client accounts holding these shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without new operational or financial disclosures.
Positives
- Increased institutional interest or a significant stake taken by Whitefort Capital Management, indicating potential confidence in OmniAb's long-term prospects.
- Clear disclosure of ownership, providing transparency to the market.
Negatives
- No new operational or financial performance data is provided in this filing, limiting insight into the company's current health.
Risks
- Potential for future changes in beneficial ownership by Whitefort Capital Management, which could impact share price volatility.
- Concentration of ownership by a single entity could influence corporate governance decisions.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding OmniAb's future performance. It solely reports on beneficial ownership.
Management Comments
- Whitefort Capital Management, LP acts as the investment manager of certain client accounts.
- David Salanic and Joseph Kaplan are Co-Managing Partners of Whitefort Management and may be deemed to have voting and dispositive power over shares held in client accounts.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes. The biotech sector, where OmniAb operates, often sees active investment from specialized funds.
Stakeholder Impact
- Shareholders: Increased transparency regarding a significant ownership stake, potentially influencing market perception and trading activity.
- Management: May face increased scrutiny or engagement from Whitefort Capital Management regarding corporate strategy and governance.
Next Steps
- Continued monitoring of OmniAb's operational and financial performance through subsequent SEC filings.
- Observation of any further changes in beneficial ownership reported by Whitefort Capital Management or other entities.
Key Dates
| Date | Description |
|---|---|
| 04/30/2026 | Date of outstanding shares reported on Issuer's Form 10-Q. |
| 05/07/2026 | Date OmniAb's Form 10-Q was filed. |
| 06/06/2025 | Date of previous Schedule 13G filing referenced. |
| 06/30/2026 | Event date requiring filing of this statement (close of business). |
| 08/14/2026 | Date of signatures on the Schedule 13G filing. |
Keywords
OmniAb, Whitefort Capital Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Ownership Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.